Integrating a Parenting Intervention Into Substance Use Treatment: A Feasibility Study
NCT ID: NCT04784858
Last Updated: 2021-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
34 participants
OBSERVATIONAL
2021-05-01
2022-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parenting Intervention for Mothers With Substance Use Disorder
NCT06489522
Trial of Mentalization-Based Therapy for Substance Using Mothers of Infants and Toddlers
NCT01240993
Promoting Co-Parenting and Reducing Hazardous Drinking in New Families
NCT04441307
Facilitating Treatment Entry and Family Planning in Substance-using Neonatal Intensive Care Unit (NICU) Mothers
NCT03165565
Home-Based Program to Help Parents of Drug Abusing Adolescents
NCT01591239
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women that are clients of participating ECD agencies
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Niagara Health System
OTHER
house of sophrosyne
UNKNOWN
Toronto Metropolitan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen Milligan
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen Milligan, PhD
Role: PRINCIPAL_INVESTIGATOR
Toronto Metropolitan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ryerson University
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABCforECD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.